Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX · Real-Time Price · USD
1.560
-0.020 (-1.27%)
Jul 10, 2025, 4:00 PM - Market closed
Repare Therapeutics Market Cap
Repare Therapeutics has a market cap or net worth of $66.91 million as of July 11, 2025. Its market cap has decreased by -55.47% in one year.
Market Cap
66.91M
Enterprise Value
-55.95M
1-Year Change
-55.47%
Ranking
Category
Stock Price
$1.56
Market Cap Chart
Since June 19, 2020, Repare Therapeutics's market cap has decreased from $945.76M to $66.91M, a decrease of -92.93%. That is a compound annual growth rate of -40.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2025 | 66.91M | 20.15% |
| Dec 31, 2024 | 55.69M | -81.89% |
| Dec 29, 2023 | 307.55M | -50.18% |
| Dec 30, 2022 | 617.25M | -29.87% |
| Dec 31, 2021 | 880.19M | -30.20% |
| Dec 31, 2020 | 1.26B | 33.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 706.50B |
| Johnson & Johnson | 374.02B |
| AbbVie | 334.70B |
| Novo Nordisk | 308.12B |
| UnitedHealth Group | 277.49B |
| Novartis AG | 240.05B |
| Abbott Laboratories | 232.25B |
| AstraZeneca | 216.19B |